Free Malaysia Today on MSN
AI-designed vaccine clears first human trial, but questions remain
Researchers hope the experimental jab could one day protect against entire families of coronaviruses, including future ...
A phase 3 randomized controlled trial published in has found that the antiviral drug Ensitrelvir significantly reduced ...
With the latest hantavirus outbreak that occurred aboard the MV Hondius cruise ship in 2026, many people are understandably ...
In a significant breakthrough, scientists at the University of Cambridge along with DIOSynVax a spin-out company from the ...
The inconvenience of having to get a new vaccine every time a new variant emerges may soon become a thing of the past. A ...
Scientists at the University of Cambridge used AI to find a kink in the armor of coronaviruses, including SARS-CoV-2, the ...
The experimental jab is intended to be a "universal vaccine" which protects people against a range of viruses that have ...
Scientists say COVID “superdodgers” do exist, but why haven’t they contracted it? Could it be a genetic immunity?
The 2026 epidemic of Ebola virus disease caused by Bundibugyo virus (species Orthoebolavirus bundibugyoense) in DR Congo and Uganda has been declared a public health emergency of international concern ...
The FDA has approved the oral antiviral Xocova (ensitrelvir) for postexposure prophylaxis of COVID-19 in adults and adolescents.
A key step in the origin of many pandemics occurs when an animal-borne virus infects humans and then evolves to spread more efficiently from person to person. That is why scientists and physicians ...
Shionogi Announces FDA Approval of XOCOVA®, the First and Only Oral Option to Help Prevent COVID-19 Following Exposure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results